Kwality Pharmaceuticals Limited

Web: kwalitypharma.com NSE: KPL BSE: 539997 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

2674 24(-1%)

Near 52W High of 2890

Volume

29k as on 19, Jun

Open

860

High

894

Low

860

2,698

VWAP

2,448

52 Week High

2,890

52 Week Low

1,561

Viand Research Rating

Quality Score

83/100

Growth Score

97/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,774

No. of Shares

1.04

P/E

32.41

P/B

4.17

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

12.86

ROCE

Profit Growth

Listing Date

Promoter Holding

54.87%

FII Holding

2.79%

DII Holding

0.36%

Price Chart

Price Performance

1 Week0%

1 Month24%

3 Months49%

6 Months49%

1 Year49%

YTD49%

Moving Average

5 Day SMA2,402

10 Day SMA2,398

20 Day SMA2,334

30 Day SMA2,162

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	2,508	2,373	2,449	2,528
Resistance 2	2,449	2,363	2,406	2,459
Resistance 1	2,396	2,353	2,380	2,416
Pivot Point	2,337	2,343	2,337	2,347
Support 1	2,284	2,332	2,294	2,304
Support 2	2,225	2,322	2,268	2,235
Support 3	2,172	2,312	2,225	2,192

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 54.87%	(0.01) 54.82%	(0.01) 54.82%	(0.01) 54.82%	(0.01) 54.82%	(0.01) 54.82%	(0.01) 54.82%	(0.01) 54.82%	(0.11) 54.82%	(0.01) 54.76%	(0.01) 54.76%	(0.01) 54.73%	(0.31) 54.73%	(0.01) 54.44%	(0.01) 54.44%	(0.01) 54.45%	(0.21) 54.43%	(0.01) 54.24%
FIIs	(2.31) 2.79%	(0.51) 0.50%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.01) 0.36%	(0.01) 0.33%	(0.01) 0.33%	(0.01) 0.33%	(0.31) 0.32%	(0.01) 0.03%	(0.01) 0.02%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	41.99%	44.33%	44.83%	44.86%	44.86%	45.14%	45.15%	45.18%	45.17%	45.22%	45.22%	45.25%	45.25%	45.54%	45.56%	45.55%	45.57%	45.76%
No. of Shareholders	10,555	10,709	11,595	10,115	9,420	8,947	7,487	5,273	5,695	5,786	6,291	6,943	6,211	5,376	4,198	1,049	581	379

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	157	123	111	111	116	84	90	80	92	78	70	67	69	56	56	70	64	88.19	183.74
Sales Growth % (YoY)	35.8%	46.2%	23.4%	39.2%	25.8%	8.1%	29.3%	18.7%	33.7%	39%	24.8%	-3.9%	7.4%	-36.3%	-69.6%	-41.6%	-	-	-
Sales Growth % (QoQ)	27.6%	10.8%	-	-4.3%	38.1%	-6.7%	12.5%	-13%	17.9%	11.4%	4.5%	-2.9%	23.2%	-	-20%	9.4%	-27.4%	-52%	-
Expenses	118	93	86	87	90	67	70	63	71	61	54	54	57	41	40	52	48	63.66	100.35
Operating Profit	39	30	25	24	26	18	20	17	21	17	15	14	11	15	16	18	16	24.53	83.39
OPM %	25	24	23	22	22	21	22	22	22	21	22	20	17	27	28	26	25	27.81	45.38
Other Income	1	0	1	0	1	1	0	0	-7	1	0	0	-15	0	1	0	2	0.84	0.12
Interest	3	2	3	3	2	2	3	2	3	3	2	2	2	2	1	1	1	0.5	0.71
Depreciation	5	5	5	5	5	5	5	4	5	5	5	5	4	4	4	3	3	3.2	2.66
Profit before tax	32	22	18	17	19	11	13	11	6	10	8	7	-10	10	12	14	14	21.67	80.14
Tax %	20	28	23	30	24	25	33	25	29	21	24	25	-24	28	19	25	25	26.77	25.61
Net Profit	25	16	14	12	14	9	8	8	4	8	6	5	-7	7	9	11	10	15.86	59.62
Net Profit Growth % (QoQ)	56.2%	14.3%	16.7%	-14.3%	55.6%	12.5%	-	100%	-50%	33.3%	20%	171.4%	-200%	-22.2%	-18.2%	10%	-36.9%	-73.4%	-
Net Profit Growth % (YoY)	78.6%	77.8%	75%	50%	250%	12.5%	33.3%	60%	157.1%	14.3%	-33.3%	-54.5%	-170%	-55.9%	-84.9%	-	-	-	-
TTM Net Profit	67	56	49	43	39	29	28	26	23	12	11	14	20	37	45.86	96.48	85.48	75.48	0
EPS in Rs	24.38	15.43	13.61	11.5	13.96	8.22	8.16	8.06	4.2	7.41	6.01	5.22	-7.11	6.84	9.08	10.16	10.12	15.29	57.48

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
Sales	503	370	307	251	456	262	139	166	137	98	74	52	60
Sales Growth %	35.9%	20.5%	22.4%	-45%	74.1%	88.1%	-16.1%	20.8%	39.9%	32.5%	41.8%	-12.2%	-
Expenses	385	290	241	190	285	233	125	150	126	89	69	49	56
Operating Profit	118	80	66	61	172	29	14	16	12	9	5	3	4
OPM %	24	22	22	24	38	11	10	9	8	9	7	6	6
Other Income	2	2	-5	-14	4	2	4	1	1	1	0	0	0
Interest	11	10	10	7	3	3	3	2	2	2	1	1	1
Depreciation	20	18	20	15	11	6	4	3	3	3	2	1	1
Profit before tax	89	54	31	26	162	21	11	11	7	6	2	1	2
Tax %	25	26	24	25	26	30	25	31	39	42	48	41	47
Net Profit	67	40	24	19	120	15	8	8	4	3	1	1	1
Net Profit Growth %	67.5%	66.7%	26.3%	-84.2%	700%	87.5%	-	100%	33.3%	200%	-	-	-
EPS in Rs	64.91	38.41	22.94	18.67	115.64	14.6	8.02	7.28	4.39	3.23	1.55	0.92	0.93
Dividend Payout %	0	0	0	0	0	0	0	0	0	9	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
Cash from Operating Activity	17	53	43	41	61	27	6	14	-1	4	-3	1	-1
Cash from Investing Activity	-35	-29	-26	-48	-63	-23	-18	-12	-6	-7	-2	-1	-3
Cash from Financing Activity	7	-14	-17	1	6	1	12	-2	5	5	6	1	3
Net Cash Flow	-11	10	-1	-6	3	4	0	0	-1	2	0	1	-1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
Equity Capital	10	10	10	10	10	10	10	10	10	10	10	5	5	4	4
Reserves	321	280	254	231	214	190	171	51	36	27	19	20	17	15	13
Borrowings	130	110	112	103	98	90	54	41	35	29	26	19	13	8	6
Other Liabilities	130	77	71	50	72	70	105	64	52	39	40	26	17	10	12
Total Liabilities	592	478	447	394	394	361	341	166	133	105	96	71	51	37	35
Fixed Assets	156	144	146	138	139	120	92	57	43	29	20	17	13	13	13
CWIP	17	0	0	0	0	14	12	3	0	0	0	0	0	0	0
Investments	0	0	0	0	0	0	0	5	4	5	5	4	2	1	1
Other Assets	420	334	302	256	255	226	237	102	86	71	70	50	37	24	22
Total Assets	592	478	447	394	394	361	341	166	133	105	96	71	51	37	35

Delivery

#	Date	1654 75% 2890	Value (Cr)	Q/T 9	Del 50	Del 11
1	22-Jul	2698	3	8	64	2
2	21-Jul	2687	3	6	57	1
3	20-Jul	2743	4	6	45	2
4	17-Jul	2702	6	5	42	3
5	16-Jul	2817	11	6	45	5
6	15-Jul	2706	8	7	47	4
7	14-Jul	2640	2	5	47	1
8	13-Jul	2655	5	6	47	2
9	10-Jul	2600	5	6	42	2
10	9-Jul	2624	7	6	46	3
11	8-Jul	2568	8	5	35	3
12	7-Jul	2550	8	6	47	4
13	6-Jul	2652	4	6	58	2
14	3-Jul	2679	8	6	45	4
15	2-Jul	2746	4	6	40	2
16	1-Jul	2702	10	6	46	5
17	30-Jun	2802	25	6	34	9
18	29-Jun	2705	34	10	44	15
19	25-Jun	2439	5	10	76	4
20	24-Jun	2455	4	7	63	2
21	23-Jun	2395	5	6	50	3
22	22-Jun	2423	6	7	53	3
23	19-Jun	2485	7	8	57	4
24	18-Jun	2343	8	10	53	4
25	17-Jun	2361	6	8	59	4
26	16-Jun	2414	6	8	48	3
27	15-Jun	2408	8	7	50	4
28	12-Jun	2493	10	8	36	4
29	11-Jun	2362	11	8	39	4
30	10-Jun	2507	44	10	25	11
31	9-Jun	2339	5	7	54	3
32	8-Jun	2271	4	8	60	3
33	5-Jun	2371	5	9	47	2
34	4-Jun	2375	5	6	50	2
35	3-Jun	2345	6	7	55	3
36	2-Jun	2299	5	6	48	2
37	1-Jun	2219	8	6	52	4
38	29-May	2310	12	6	42	5
39	27-May	2237	9	8	41	4
40	26-May	2164	8	8	55	4
41	25-May	2233	25	13	46	11
42	22-May	2137	5	10	48	2
43	21-May	2087	12	10	46	6
44	20-May	2056	55	12	27	15
45	19-May	2001	88	14	24	21
46	18-May	1836	9	7	48	4
47	15-May	1719	1	6	63	1
48	14-May	1681	1	6	47	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	2,774c	17c	0.61
22-Jul	2,791c	31c	1.10
21-Jul	2,822c	25c	0.89
17-Jul	2,797c	144c	4.90
16-Jul	2,942c	171c	6.19
15-Jul	2,770c	56c	2.07
14-Jul	2,714c	53c	1.93
13-Jul	2,767c	2c	0.06
10-Jul	2,769c	45c	1.66
09-Jul	2,724c	47c	1.74
08-Jul	2,677c	35c	1.32
07-Jul	2,642c	113c	4.09
06-Jul	2,755c	177c	6.02
30-Jun	2,931c	205c	7.53
29-Jun	2,726c	184c	7.22
26-Jun	2,542c	31c	1.24
25-Jun	2,511c	41c	1.59
24-Jun	2,552c	56c	2.25
23-Jun	2,496c	20c	0.81
22-Jun	2,516c	68c	2.62
19-Jun	2,584c	139c	5.69
17-Jun	2,445c	82c	3.24
16-Jun	2,527c	22c	0.87
15-Jun	2,505c	78c	3.01
12-Jun	2,583c	35c	1.35
11-Jun	2,618c	16c	0.59
10-Jun	2,634c	0	0

Stock Checklist

Price is above from 52 week high low average: 67%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: YES

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Jul26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.05%	-	0

Kwality Pharmaceuticals Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements